Editing Available Guidelines: ESMO Guidelines

'''Breast Cancer''':

* Metastatic Breast Cancer
* Breast cancer in the COVID-19 era
* Consensus Recommendations – Breast Cancer in Young Women (BCY5)
* Early Breast Cancer
* Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes


'''Cancers of Unknown Primary Site''': 

* Cancers of Unknown Primary Site


'''Endocrine and Neuroendocrine Cancers''': 
* Adrenocortical Carcinomas and Malignant Phaeochromocytomas
* Gastroenteropancreatic Neuroendocrine Neoplasms
* Lung and Thymic Carcinoids
* Thyroid cancer


'''Gastrointestinal Cancers''':

* Anal Cancer
* Biliary Tract Cancer
* Gastric Cancer
* Gastrointestinal cancers: Colorectal cancer (CRC) in the COVID-19 era
* Gastrointestinal cancers: Gastro-oesophageal tumors in the COVID-19 era
* Gastrointestinal cancers: Pancreatic cancer in the COVID-19 era
* Hepatocellular Carcinoma
* Hereditary Gastrointestinal Cancers
* Localised Colon Cancer
* Metastatic Colorectal Cancer
* Oesophageal Cancer; Pancreatic Cancer
* Rectal Cancer


'''Genitourinary Cancers''': 

* Bladder Cancer
* Penile Carcinoma
* Prostate Cancer
* Renal Cell Carcinoma
* Testicular Cancer


'''Gynaecological Cancers''': 
* Cervical Cancer
* Endometrial Cancer
* Gestational Trophoblastic Disease
* Gynaecological malignancies: Cervical cancer in the COVID-19 era
* Gynaecological malignancies: Endometrial cancer in the COVID-19 era
* Gynaecological malignancies: Epithelial ovarian cancer in the COVID-19 era
* Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma
* Non-Epithelial Ovarian Cancer
* Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes


'''Haematological Malignancies''':

* Acute Lymphoblastic Leukaemia
* Acute Myeloid Leukaemia
* Chronic Lymphocytic Leukaemia
* Chronic Myeloid Leukaemia
* Diffuse Large B-Cell Lymphoma
* Elderly Patient with Malignant Lymphoma
* Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
* Follicular Lymphoma
* Hairy Cell Leukaemia
* Hodgkin Lymphoma
* Management of ultra-high-risk Patients
* Mantle Cell Lymphoma
* Marginal Zone Lymphomas
* Multiple Myeloma
* Myelodysplastic Syndromes
* Peripheral T-Cell Lymphomas
* Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
* Primary Cutaneous Lymphoma
* Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia
* Waldenstrom’s Macroglobulinaemia


'''Head and Neck Cancers''':

* Nasopharyngeal Carcinoma
* Salivary Gland Cancer
* Squamous Cell Carcinoma of the Head and Neck


'''Hereditary Syndromes''':

* Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes
* Hereditary Gastrointestinal Cancers


'''Lung and Chest Tumours''':

* Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer
* Lung cancer in the COVID-19 era; Malignant Pleural Mesothelioma
* Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer
* Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer
* Small-Cell Lung Cancer
* Thymic Epithelial Tumours


'''Melanoma''':

* Cutaneous Melanoma

'''Neuro-Oncology''': 

* Leptomeningeal Metastasis
* High-Grade Malignant Glioma
* Neurological and Vascular Complications of Primary and Secondary Brain Tumours
* Brain Metastasis from Solid Tumours


'''Sarcoma and GIST''':

* Bone Sarcomas
* Soft Tissue and Visceral Sarcomas
* Gastrointestinal Stromal Tumours


'''Supportive and Palliative Care''': 

* Palliative Care in the COVID-19 era
* Advanced Care Planning
* Anxiety and Depression
* Anaemia and Iron Deficiency in Patients With Cancer
* Bone Health in Cancer Patients
* Cancer Cachexia in Adult Patients
* Cancer Pain
* Cancer-related Fatigue
* Care at the End of Life
* Central Venous Access in Oncology
* Chemotherapy Extravasation
* Constipation in Advanced Cancer
* Delirium in Adult Cancer Patients
* Diarrhoea in Adult Cancer Patients
* Febrile Neutropaenia
* Fertility Preservation and Post-treatment Pregnancies in Post-pubertal Cancer Patients
* Infusion Reactions to Systemic Anticancer Therapy
* Management of Breathlessness in Patients with Cancer
* Management of Cardiac Disease; Management of Orphan Symptoms
* Neurotoxicity; Oral and Gastrointestinal Mucosal Injury
* Prevention and Management of Dermatological Toxicities Related to Anticancer Agents
* Prevention of Chemotherapy and Radiotherapy-Induced Nausea and Vomiting
* Prognostic Evaluation in Advanced Cancer
* Role of Patient-reported Outcome Measures
* Toxicities from immunotherapy and Venous Thromboembolism in Cancer Patients